Abstract: Lung cancer is a type of malignant tumor with high heterogeneity and presents with controversial diagnosis, uncertain prognosis, and debated forms of treatment. Currently, lung cancer management shows a developmental trend of personalized, precise, multidisciplinary, and comprehensive treatment. Based on evidence-based medicine, multidisciplinary teams (MDT) integrate the best evidence, expert experience, and patient wishes, which reduces bias in the selection of specialists and emphasizes changes in diagnosis and treatment decisions for patients. MDT can effectively improve clinical benefits in patients, optimize the use of medical resources, improve the rationality of diagnosis and treatment, introduce new ideas from scientific research, and finally benefit both doctors and patients in many ways. To standardize the development of MDT diagnosis and treatment of lung cancer in China, members of the Chinese Thoracic Oncology Group; Chinese Society of Lung Cancer; Lung Cancer Group of Oncology Branch, Chinese Medical Association; and the Multidisciplinary Team Diagnosis and Treatment Committee, Chinese Medical Doctor Association jointly published a Chinese expert consensus on multidisciplinary team diagnosis and treatment of lung cancer. This article interprets the consensus in reference to four perspectives: MDT preparation, implementation, later stage, and practical application.